Cumberland Pharmaceuticals (CPIX) Stock Statistics & Valuation Metrics

Cumberland Pharmaceuticals has a market cap or net worth of $48.61M. The enterprise value is $47.34M.

Cumberland Pharmaceuticals has 14,956,627 shares outstanding. The number of shares has decreased by -2.65% in one year.

Cumberland Pharmaceuticals’s return on equity (ROE) is -0.11 and return on invested capital (ROIC) is -6.89%.

The current PE Ratio of Cumberland Pharmaceuticals is ―. Cumberland Pharmaceuticals’s PEG ratio is 0.36.

In the last 12 months, Cumberland Pharmaceuticals had revenue of 44.52M and earned -2.84M in profits. Earnings per share was -0.19.

In the last 12 months, operating cash flow was 4.93M and capital expenditures -97.90K, giving a free cash flow of 4.83M billion.

Cumberland Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Cumberland Pharmaceuticals upcoming earnings date is May 12, 2026, After Close (Confirmed).

Cumberland Pharmaceuticals as a current ratio of 1.01, with Debt / Equity ratio of 40.92%

In the past 12 months, Cumberland Pharmaceuticals has paid 40.26K in taxes.

Cumberland Pharmaceuticals EV to EBITDA ratio is 23.36, with an EV/FCF ratio of 12.05.

Cumberland Pharmaceuticals has $11.44M in cash and marketable securities with $10.18M in debt, giving a net cash position of $1.26M billion.

Gross margin is 85.02%, with operating margin of -6.27%, and net profit margin of -6.37%.

The average price target for Cumberland Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―